A Randomized, Single Dose, Open Label, 2-Way Crossover Comparative Bioavailability Study of Mecobalamin Nasal Spray 250 mcg/0.05 mL with Methycobal Injection (Mecobalamin 100 mcg/0.2 mL Intramuscular Injection)in Healthy Human Subjects under Fasting Conditions.

Trial Profile

A Randomized, Single Dose, Open Label, 2-Way Crossover Comparative Bioavailability Study of Mecobalamin Nasal Spray 250 mcg/0.05 mL with Methycobal Injection (Mecobalamin 100 mcg/0.2 mL Intramuscular Injection)in Healthy Human Subjects under Fasting Conditions.

Completed
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 07 Sep 2016

At a glance

  • Drugs Mecobalamin (Primary) ; Mecobalamin
  • Indications Unspecified
  • Focus Pharmacokinetics
  • Sponsors Troikaa Pharmaceuticals
  • Most Recent Events

    • 07 Sep 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top